John Duncan Higgons

CIK 1581954 · Chief Operating Officer · last filed 2022-06-28

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.56M

Companies

2

Total Filings

46

Lifetime Open-Market Net

-$21.37M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Jounce Therapeutics, Inc. (JNCE) Delisted Director 9,713 $1.88 $18.3K $67.9K 12 2022-06-28
AGIO Chief Operating Officer 120,834 $29.46 $3.56M -$21.43M 34 2016-01-05

Recent Filings · Page 3 of 5

46 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-08-21 AGIO Exer (M) +10,000 $3.0K EDGAR
2015-08-19 AGIO Mixed -$1.84M EDGAR
2015-08-10 AGIO Exer (M) +10,000 $3.0K EDGAR
2015-07-17 AGIO Mixed -$2.27M EDGAR
2015-06-16 AGIO Sell (S) −7,000 -$736.6K EDGAR
2015-06-12 AGIO Exer (M) +30,000 $9.1K EDGAR
2015-05-18 AGIO Sell (S) −7,417 -$837.3K EDGAR
2015-04-17 AGIO Sell (S) −6,583 -$655.3K EDGAR
2015-03-18 AGIO Sell (S) −7,000 -$743.7K EDGAR
2015-03-03 AGIO Grant (A) $0 EDGAR
Showing 2130 of 46
Page 3 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.